Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$10.59 USD
+0.81 (8.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.60 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Shattuck Labs, Inc. [STTK]
Reports for Purchase
Showing records 21 - 26 ( 26 total )
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Results; SL-172154 Advances; Phase 1b Study in PROC Expected to Begin Shortly; Multiple Readouts by 1H23
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Magrolimab Green Light From FDA and ASCO Updates Bode Well for SL-172154
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
BMY Engages Gamma Delta T-cells; We Believe This Bolsters GADLEN Visibility
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
1Q22 Results; Bolstered by Strong Cash Position, Lead Assets Continue Rapid Progress in the Clinic
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Modular Therapies Packing a Powerful One-Two Punch; Initiating at Buy and $28 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J